Researchers at UQ’s Queensland Brain Institute (QBI) have highlighted how acetylcholine signalling interacts with dopamine pathways in the brain, findings that may help explain how a new class of schizophrenia treatments works.
QBI's Professor Eyles and his team have developed a novel intranasal formulation of the antipsychotic drug, clozapine, that may revolutionise the treatment of schizophrenia.
A University of Queensland (UQ) research team led by Professor Darryl Eyles has developed a novel intranasal formulation of clozapine that could transform the treatment of schizophrenia.
Antipsychotic drugs, like clozapine, can stabilise some schizophrenia symptoms, but they do not cure the illness and can cause severe side effects. QBI's Professor Darryl Eyles and Dr Xiaoying Cui are investigating a new delivery mode for clozapine.
Svetlina Vasileva, a PhD student in the Eyles lab, has led a study to explore associations between the composition of the gut microbiome, schizophrenia and its treatment.
